DOCSLIB.ORG

Diagnosis and Management of Heavy Menstrual Bleeding and Bleeding Disorders in Adolescents

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Diagnosis and Management of Heavy Menstrual Bleeding and Bleeding Disorders in Adolescents Clinical Review & Education JAMA Pediatrics | Review Diagnosis and Management of Heavy Menstrual Bleeding and Bleeding Disorders in Adolescents Claudia Borzutzky, MD; Julie Jaffray, MD Supplemental content IMPORTANCE Heavy menstrual bleeding is a common cause of anemia and reduced quality of life in adolescents. There is a higher prevalence of bleeding disorders in girls with heavy menstrual bleeding than in the general population. Pediatricians should be comfortable with the initial evaluation of heavy menstrual bleeding and the indications for referral to subspecialty care. OBSERVATIONS The most common cause of heavy menstrual bleeding in adolescents is ovulatory dysfunction, followed by coagulopathies. The most common inherited bleeding disorder is von Willebrand disease, and its incidence in adolescents with heavy menstrual bleeding is high. Distinguishing the etiology of heavy menstrual bleeding will guide Author Affiliations: Keck School of treatment, which can include hemostatic medications, hormonal agents, or a combination of Medicine of University of Southern California, Los Angeles (Borzutzky, both. Among hormonal agents, the 52-mg levonogestrel intrauterine device has been shown Jaffray); Division of Adolescent and to be superior in its effect on heavy menstrual bleeding and is safe and effective in Young Adult Medicine, Department adolescents with bleeding disorders. of Pediatrics, Children’s Hospital Los Angeles, Los Angeles, California CONCLUSIONS AND RELEVANCE Anemia, need for transfusion of blood products, and (Borzutzky); Children’s Center for hospitalization may be avoided with prompt recognition, diagnosis, and treatment of heavy Cancer and Blood Diseases, Department of Pediatrics, Children’s menstrual bleeding, especially when in the setting of bleeding disorders. Safe and effective Hospital Los Angeles, Los Angeles, treatment methods are available and can greatly improve quality of life for affected California (Jaffray). adolescents. A multidisciplinary approach to the treatment of girls with bleeding disorders Corresponding Author: Claudia and history of heavy menstrual bleeding is optimal. Borzutzky, MD, Division of Adolescent and Young Adult Medicine, Children’s Hospital JAMA Pediatr. doi:10.1001/jamapediatrics.2019.5040 Los Angeles, 4650 Sunset Blvd, Published online December 30, 2019. M/S 2, Los Angeles, CA 90027 ([email protected]). chieving menarche and having regular menstrual peri- especially when associated with prolonged or frequent menses, can ods are critical developmental milestones in the life of lead to anemia, fatigue, and hemodynamic instability. These may re- A an adolescent girl. However, for many teenagers, men- sult in associated emergency department visits, hospitalizations, the ses can be a source of distress and medical morbidity, particularly need for transfusion of blood products, and the use of oral and intra- when menses is excessively heavy, frequent, or prolonged. This is venoustherapiestostopbloodloss.Bleedingdisordersarenotuncom- especially true when heavy menstrual bleeding (HMB) is associ- moninfemaleadolescents,andprevalenceofBDamonggirlswithHMB ated with a congenital or acquired bleeding disorder (BD). The is much higher than that for the general population.4,5 etiology and management of HMB in adolescents, with and with- out a BD, has been understudied. This review will explore what is known about HMB in adolescents, as well as the coincidence of a Normal Menstrual Cycle and Abnormalities BD with HMB, and how diagnostic work up and management should vary accordingly. in Menstruation: Definitions and Terms Heavy menstrual bleeding is a common problem in adoles- Normal Menstrual Cycle cent girls and a frequent reason for visits to primary care physi- The normal menstrual cycle (Figure 1)6 depends on the feedback cians, as well as referrals to hematology, adolescent medicine loops of estrogen and progesterone on the production of luteiniz- specialists, and gynecologists. Reported prevalence of HMB ing hormone and follicle-stimulating hormone by the pituitary ranges from 34% to 37%.1,2 Quality of life (QOL) can be signifi- gland and on the hypothalamus’s normal function as metronome cantly affected, manifested in missed school days, physical activ- for the hypothalamic-pituitary-ovarian axis.7 According to ACOG, ity limitations, and need for prolonged periods of rest.1 the mean age for menarche in the United States remains around TheAmericanCollegeofObstetriciansandGynecologists(ACOG) 12.5 years; cycle intervals range from 21 to 45 days (averaging 32 has endorsed the use of the menstrual cycle as a vital sign3;ie,anor- days); menstrual flow is 7 days or less; and normal daily menstrual mal menstrual cycle is an essential element of overall health, while an product use ranges from 3 to 6 regular pads or tampons.3 Normal abnormal menstrual cycle can reflect medical illness, iatrogenic prob- cycles may vary up to 9 days in length, although parameters for lems, or hypothalamus-mediated stress. Heavy menstrual bleeding, teenagers have not been well characterized.8 jamapediatrics.com (Reprinted) JAMA Pediatrics Published online December 30, 2019 E1 © 2019 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ by Kim Roque on 01/09/2020 Clinical Review & Education Review Diagnosis and Management of Heavy Menstrual Bleeding and Bleeding Disorders in Adolescents Figure 1. Hypothalamic Pituitary Ovarian Axis and Normal Menstrual Cyclea A Hypothalamic pituitary ovarian axis B Normal menstrual cycle Hypothalamus Hypothalamus LH P FSH/LH Endocrine E2 GnRH cycle FSH CRF Pituitary gland T4 TRF Follicular Luteal phase phase T4 Ovarian Dominant follicle histology Corpus luteum Proliferative Secretory phase phase ACTH TSH Cortisone Thyroid Endometrial histology E2 Adrenal inhibin 0 14 28 gland Cycle Day Menses Ovary ACTH indicates adrenocorticotropic hormone; CRF, corticotropin-releasing thyrotropin-releasing factor; T4, thyroxine; TSH, thyrotropin. hormone; E2, estradiol; FSH, follicle-stimulating hormone; GnRH, a Reproduced with permission from Berek, 2012.6 gonadotropin-releasing hormone; LH, luteinizing hormone; TRF, Abnormal Uterine Bleeding Simultaneous to proposing its new classification system, Abnormal uterine bleeding (AUB) is a term recently favored over FIGO issued a recommendation on the nomenclature used to the previously used dysfunctional uterine bleeding (DUB), and per describe menstrual function, in which confusing, previously used ACOG refers to “menstrual flow outside of normal volume, dura- terms such as menorrhagia, metrorrhagia, polymenorrhea, and tion, regularity, or frequency.”9 In 2011, the Federation of Interna- menometrorrhagia are discarded in favor of the terms used in tional Gynecology and Obstetrics (FIGO) proposed a new classifi- Figure 2: HMB and intermenstrual bleeding, as well as heavy and cation system for causes of AUB, PALM-COEIN10 (Polyp, prolonged menstrual bleeding.13 The Federation of International Adenomyosis, Leiomyoma, Malignancy and hyperplasia, Coagu- Gynecology and Obstetrics also suggested parameters for lopathy, Ovulatory dysfunction, Endometrial, Iatrogenic, and Not normal/abnormal menses for the midreproductive years (eTable yet classified) (Figure 2), which was endorsed by ACOG in 20129 in the Supplement); parameters for the perimenarchal years are and revised in 2018.8 not specified. Although HMB, one symptom of AUB, has previously been defined as a quantification of hemoglobin or an estimation of Primary and Secondary Hemostasis menstrual blood loss by volume (>80 mL),11 the newer FIGO A woman’s monthly menstruation takes a large toll on the hemo- recommendations8 endorse the UK National Institute for Health static system. To avoid excessive bleeding, the interaction of pro- and Care Excellence (UK NICE) clinical definition: “excessive men- coagulants and anticoagulants must be balanced. Any quantitative strual blood loss, which interferes with the woman’s physical, or qualitative disruption of the hemostatic system can lead to in- emotional, social and material QOL, and which can occur alone or creased menstrual bleeding. in combination with other symptoms.”12 This definition relies on Primary hemostasis involves the integration of platelets and a the patient’s lived experience, rather than rigid criteria involving glycoprotein called von Willebrand factor (VWF). Initiation of pri- difficult measurements, and should be applied when treating mary hemostasis begins with injury to the blood vessel wall. This adolescents. injury allows exposure of collagen, elastin, and VWF,14 which E2 JAMA Pediatrics Published online December 30, 2019 (Reprinted) jamapediatrics.com © 2019 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ by Kim Roque on 01/09/2020 Diagnosis and Management of Heavy Menstrual Bleeding and Bleeding Disorders in Adolescents Review Clinical Review & Education Figure 2. Federation of International Gynecology and Obstetrics Figure 3. Diagnostic Testing for Disorders of Primary Classification for Causes of Abnormal Uterine Bleeding: PALM-COEINa and Secondary Hemostasis PALM: Structural causes of AUB Quantitative platelet Polyp evaluation: Adenomyosis CBC Leiomyoma Qualitative platelet Malignancy and hyperplasia evaluation: VWD evaluation: Collagen evaluation: PFA-100 VWF: Ag, VWF: Rco Abnormal uterine bleeding (AUB) PA PA FVIII activity Heavy menstrual bleeding Hypermobility score Intermenstrual bleeding EM VWF multimers Primary hemostasis
Load more

Recommended publications
  • The Male Reproductive System
    Management of Men’s Reproductive 3 Health Problems Men’s Reproductive Health Curriculum Management of Men’s Reproductive 3 Health Problems © 2003 EngenderHealth. All rights reserved. 440 Ninth Avenue New York, NY 10001 U.S.A. Telephone: 212-561-8000 Fax: 212-561-8067 e-mail: [email protected] www.engenderhealth.org This publication was made possible, in part, through support provided by the Office of Population, U.S. Agency for International Development (USAID), under the terms of cooperative agreement HRN-A-00-98-00042-00. The opinions expressed herein are those of the publisher and do not necessarily reflect the views of USAID. Cover design: Virginia Taddoni ISBN 1-885063-45-8 Printed in the United States of America. Printed on recycled paper. Library of Congress Cataloging-in-Publication Data Men’s reproductive health curriculum : management of men’s reproductive health problems. p. ; cm. Companion v. to: Introduction to men’s reproductive health services, and: Counseling and communicating with men. Includes bibliographical references. ISBN 1-885063-45-8 1. Andrology. 2. Human reproduction. 3. Generative organs, Male--Diseases--Treatment. I. EngenderHealth (Firm) II. Counseling and communicating with men. III. Title: Introduction to men’s reproductive health services. [DNLM: 1. Genital Diseases, Male. 2. Physical Examination--methods. 3. Reproductive Health Services. WJ 700 M5483 2003] QP253.M465 2003 616.6’5--dc22 2003063056 Contents Acknowledgments v Introduction vii 1 Disorders of the Male Reproductive System 1.1 The Male
    [Show full text]
  • Prolactin Level in Women with Abnormal Uterine Bleeding Visiting Department of Obstetrics and Gynecology in a University Teaching Hospital in Ajman, UAE
    Prolactin level in women with Abnormal Uterine Bleeding visiting Department of Obstetrics and Gynecology in a University teaching hospital in Ajman, UAE Jayakumary Muttappallymyalil1*, Jayadevan Sreedharan2, Mawahib Abd Salman Al Biate3, Kasturi Mummigatti3, Nisha Shantakumari4 1Department of Community Medicine, 2Statistical Support Facility, CABRI, 4Department of Physiology, Gulf Medical University, Ajman, UAE 3Department of OBG, GMC Hospital, Ajman, UAE *Presenting Author ABSTRACT Objective: This study was conducted among women in the reproductive age group with abnormal uterine bleeding (AUB) to determine the pattern of prolactin level. Materials and Methods: In this study, a total of 400 women in the reproductive age group with AUB attending GMC Hospital were recruited and their prolactin levels were evaluated. Age, marital status, reproductive health history and details of AUB were noted. SPSS version 21 was used for data analysis. Descriptive statistics was performed to describe the population, and inferential statistics such as Chi-square test was performed to find the association between dependent and independent variables. Results: Out of 400 women, 351 (87.8%) were married, 103 (25.8%) were in the age group 25 years or below, 213 (53.3%) were between 26-35 years and 84 (21.0%) were above 35 years. Mean age was 30.3 years with a standard deviation 6.7. The prolactin level ranged between 15.34 mIU/l and 2800 mIU/l. The mean and SD observed were 310 mIU/l and 290 mIU/l respectively. The prolactin level was high among AUB patients with inter-menstrual bleeding compared to other groups. Additionally, the level was high among women with age greater than 25 years compared to those with age less than or equal to 25 years.
    [Show full text]
  • Endometriosis for Dummies.Pdf
    01_050470 ffirs.qxp 9/26/06 7:36 AM Page i Endometriosis FOR DUMmIES‰ by Joseph W. Krotec, MD Former Director of Endoscopic Surgery at Cooper Institute for Reproductive Hormonal Disorders and Sharon Perkins, RN Coauthor of Osteoporosis For Dummies 01_050470 ffirs.qxp 9/26/06 7:36 AM Page ii Endometriosis For Dummies® Published by Wiley Publishing, Inc. 111 River St. Hoboken, NJ 07030-5774 www.wiley.com Copyright © 2007 by Wiley Publishing, Inc., Indianapolis, Indiana Published by Wiley Publishing, Inc., Indianapolis, Indiana Published simultaneously in Canada No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, scanning, or otherwise, except as permit- ted under Sections 107 or 108 of the 1976 United States Copyright Act, without either the prior written permission of the Publisher, or authorization through payment of the appropriate per-copy fee to the Copyright Clearance Center, 222 Rosewood Drive, Danvers, MA 01923, 978-750-8400, fax 978-646-8600. Requests to the Publisher for permission should be addressed to the Legal Department, Wiley Publishing, Inc., 10475 Crosspoint Blvd., Indianapolis, IN 46256, 317-572-3447, fax 317-572-4355, or online at http:// www.wiley.com/go/permissions. Trademarks: Wiley, the Wiley Publishing logo, For Dummies, the Dummies Man logo, A Reference for the Rest of Us!, The Dummies Way, Dummies Daily, The Fun and Easy Way, Dummies.com, and related trade dress are trademarks or registered trademarks of John Wiley & Sons, Inc., and/or its affiliates in the United States and other countries, and may not be used without written permission.
    [Show full text]
  • Vaginitis and Abnormal Vaginal Bleeding
    UCSF Family Medicine Board Review 2013 Vaginitis and Abnormal • There are no relevant financial relationships with any commercial Vaginal Bleeding interests to disclose Michael Policar, MD, MPH Professor of Ob, Gyn, and Repro Sciences UCSF School of Medicine [email protected] Vulvovaginal Symptoms: CDC 2010: Trichomoniasis Differential Diagnosis Screening and Testing Category Condition • Screening indications – Infections Vaginal trichomoniasis (VT) HIV positive women: annually – Bacterial vaginosis (BV) Consider if “at risk”: new/multiple sex partners, history of STI, inconsistent condom use, sex work, IDU Vulvovaginal candidiasis (VVC) • Newer assays Skin Conditions Fungal vulvitis (candida, tinea) – Rapid antigen test: sensitivity, specificity vs. wet mount Contact dermatitis (irritant, allergic) – Aptima TMA T. vaginalis Analyte Specific Reagent (ASR) Vulvar dermatoses (LS, LP, LSC) • Other testing situations – Vulvar intraepithelial neoplasia (VIN) Suspect trich but NaCl slide neg culture or newer assays – Psychogenic Physiologic, psychogenic Pap with trich confirm if low risk • Consider retesting 3 months after treatment Trichomoniasis: Laboratory Tests CDC 2010: Vaginal Trichomoniasis Treatment Test Sensitivity Specificity Cost Comment Aptima TMA +4 (98%) +3 (98%) $$$ NAAT (like GC/Ct) • Recommended regimen Culture +3 (83%) +4 (100%) $$$ Not in most labs – Metronidazole 2 grams PO single dose Point of care – Tinidazole 2 grams PO single dose •Affirm VP III +3 +4 $$$ DNA probe • Alternative regimen (preferred for HIV infected
    [Show full text]
  • LNG-IUS) in Patients Affected by Menometrorrhagia, Dysmenorrhea and Adenomimyois: Clinical and Ultrasonographic Reports
    European Review for Medical and Pharmacological Sciences 2021; 25: 3432-3439 The treatment with Levonorgestrel Releasing Intrauterine System (LNG-IUS) in patients affected by menometrorrhagia, dysmenorrhea and adenomimyois: clinical and ultrasonographic reports F. COSTANZI, M.P. DE MARCO, C. COLOMBRINO, M. CIANCIA, F. TORCIA, I. RUSCITO, F. BELLATI, A. FREGA, G. COZZA, D. CASERTA Department of Surgical and Medical Sciences and Translational Medicine, Sant’Andrea University Hospital, Sapienza University of Rome, Rome, Italy Abstract. – OBJECTIVE: Adenomyosis is p=0.025; p=0.014). The blood loss decreased the consequence of the myometrial invasion significantly in both the cohorts (p<0.001) and by endometrial glands and stroma. Transvag- particularly in adenomyotic patients. Pain relief inal ultrasonography plays a decisive role in was observed in all the patients (p<0.001). the diagnosis and monitoring of this patholo- CONCLUSIONS: LNG-IUS can be considered gy. Our study aims to evaluate the efficacy of an effective treatment for managing symptoms LNG-IUS (Levonorgestrel Releasing Intrauter- and improving uterine morphology. ine System) as medical therapy. We analyzed both clinical symptoms and ultrasonograph- Key Words: ic aspects of menometrorrhagia and dysmen- Benign disease of uterus, Dysmenorrhea, Gyne- orrhea in patients with adenomyosis and the cologic imaging, Leiomyomas of the uterus/adeno- control group. myosis. PATIENTS AND METHODS: A prospective co- hort study was carried out on 28 patients suf- fering from symptomatic adenomyosis treat- ed with LNG-IUS. Adenomyosis was diagnosed Introduction through transvaginal ultrasonography by an ex- pert sonographer. A control group of 27 symp- Adenomyosis is a benign gynecological dis- tomatic patients (menorrhagia and dysmenor- ease with a large variety of clinical manifestation; rhea) without a transvaginal ultrasonograph- the most frequent include menorrhagia, metror- ic diagnosis of adenomyosis was treated in the rhagia, dysmenorrhea and chronic pelvic pain1.
    [Show full text]
  • Epidemiology of Menstrual Disorders in Developing Countries: a Systematic Review
    BJOG: an International Journal of Obstetrics and Gynaecology DOI: 10.1046/j.1471-0528.2003.00012.x January 2004, Vol. 111, pp. 6–16 REVIEW Epidemiology of menstrual disorders in developing countries: a systematic review Introduction Information on the prevalence of menstrual complaints in the past three months was obtained in seven countries In developing countries, priority setting in the health (Table 1). These data permit cross national comparisons sector traditionally focuses on the principal causes of mor- in so far as similar questions with a similar time reference tality. More recently, the Global Burden of Disease approach were asked. However, no definitions were provided and incorporates assessment of morbidity and quality of life in considerable variation in the interpretation of questions identifying priorities. Yet, although investigations in various among individuals and across cultures is likely. developing countries reveal that women are concerned by Approximately a dozen subsequent surveys, including menstrual disorders, little attention is paid to understanding community-based, clinic-based and one national census, or ameliorating women’s menstrual complaints.1 Menstrual include some information on menstrual morbidities6–29 dysfunction, like other aspects of sexual and reproductive (Table 2). A few health surveys of special populations, health, is not included in the Global Burden of Disease such as factory workers in Vietnam17 and medical students estimates2,3 and, even as reproductive health programs in Venezuela,27,28 have also included relevant questions expand their focus to address gynaecologic morbidity, the on menstrual disorders. These surveys vary consider- utility of evaluating and treating menstrual problems is ably in the definition of and reference period for men- not generally considered.
    [Show full text]
  • Changes Before the Change1.06 MB
    Changes before the Change Perimenopausal bleeding Although some women may abruptly stop having periods leading up to the menopause, many will notice changes in patterns and irregular bleeding. Whilst this can be a natural phase in your life, it may be important to see your healthcare professional to rule out other health conditions if other worrying symptoms occur. For further information visit www.imsociety.org International Menopause Society, PO Box 751, Cornwall TR2 4WD Tel: +44 01726 884 221 Email: [email protected] Changes before the Change Perimenopausal bleeding What is menopause? Strictly defined, menopause is the last menstrual period. It defines the end of a woman’s reproductive years as her ovaries run out of eggs. Now the cells in the ovary are producing less and less hormones and menstruation eventually stops. What is perimenopause? On average, the perimenopause can last one to four years. It is the period of time preceding and just after the menopause itself. In industrialized countries, the median age of onset of the perimenopause is 47.5 years. However, this is highly variable. It is important to note that menopause itself occurs on average at age 51 and can occur between ages 45 to 55. Actually the time to one’s last menstrual period is defined as the perimenopausal transition. Often the transition can even last longer, five to seven years. What hormonal changes occur during the perimenopause? When a woman cycles, she produces two major hormones, Estrogen and Progesterone. Both of these hormones come from the cells surrounding the eggs. Estrogen is needed for the uterine lining to grow and Progesterone is produced when the egg is released at ovulation.
    [Show full text]
  • Abnormal Uterine Bleeding: a Management Algorithm
    J Am Board Fam Med: first published as 10.3122/jabfm.19.6.590 on 7 November 2006. Downloaded from EVIDENCED-BASED CLINICAL MEDICINE Abnormal Uterine Bleeding: A Management Algorithm John W. Ely, MD, MSPH, Colleen M. Kennedy, MD, MS, Elizabeth C. Clark, MD, MPH, and Noelle C. Bowdler, MD Abnormal uterine bleeding is a common problem, and its management can be complex. Because of this complexity, concise guidelines have been difficult to develop. We constructed a concise but comprehen- sive algorithm for the management of abnormal uterine bleeding between menarche and menopause that was based on a systematic review of the literature as well as the actual management of patients seen in a gynecology clinic. We started by drafting an algorithm that was based on a MEDLINE search for rel- evant reviews and original research. We compared this algorithm to the actual care provided to a ran- dom sample of 100 women with abnormal bleeding who were seen in a university gynecology clinic. Discrepancies between the algorithm and actual care were discussed during audiotaped meetings among the 4 investigators (2 family physicians and 2 gynecologists). The audiotapes were used to revise the algorithm. After 3 iterations of this process (total of 300 patients), we agreed on a final algorithm that generally followed the practices we observed, while maintaining consistency with the evidence. In clinic, the gynecologists categorized the patient’s bleeding pattern into 1 of 4 types: irregular bleeding, heavy but regular bleeding (menorrhagia), severe acute bleeding, and abnormal bleeding associated with a contraceptive method. Subsequent management involved both diagnostic and treatment interven- tions, which often occurred simultaneously.
    [Show full text]
  • Too Much, Too Little, Too Late: Abnormal Uterine Bleeding
    Too much, too little, too late: Abnormal uterine bleeding Jody Steinauer, MD, MAS July, 2015 The Questions • Too much (& too early or too late) – Differential and approach to work‐up – Does she need an endometrial biopsy (EMB)? – Does she need an ultrasound? – How do I stop peri‐menopausal bleeding? – Isn’t it due to the fibroids? • Too fast: She’s hemorrhaging—what do I do? • Too little: A quick review of amenorrhea Case 1 A 46 yo G3P2T1 reports her periods have become 1. What term describes increasingly irregular and heavy her symptoms? over the last 6‐8 months. 2. Physiologically, what Sometimes they come 2 times causes this type of per month and sometimes there bleeding pattern? are 2 months between. LMP 2 3. What is the months ago. She bleeds 10 days differential? with clots and frequently bleeds through pads to her clothes. She occasionally has hot flashes. She also has diabetes and is obese. Q1: In addition to a urine pregnancy test and TSH, which of the following is the most appropriate test to obtain at this time? 1. FSH 2. Testosterone & DHEAS 3. Serum beta‐HCG 4. Transvaginal Ultrasound (TVUS) 5. Endometrial Biopsy (EMB) Terminology: What is abnormal? • Normal: Cycle= 28 days +‐ 7 d (21‐35); Length=2‐7 days; Heaviness=self‐defined • Too little bleeding: amenorrhea or oligomenorrhea • Too much bleeding: Menorrhagia (regular timing but heavy (according to patient) OR long flow (>7 days) • Irregular bleeding: Metrorrhagia, intermenstrual or post‐ coital bleeding • Irregular and Excessive: Menometrorrhagia • Preferred term for non‐pregnant bleeding issues= Abnormal Uterine Bleeding (AUB) – Avoid “DUB” ‐ dysfunctional uterine bleeding.
    [Show full text]
  • Dell Childrens Hospital
    DELL CHILDREN’S MEDICAL CENTER EVIDENCE-BASED OUTCOMES CENTER Abnormal Uterine Bleeding Heavy Menstrual Bleeding in Adolescents LEGAL DISCLAIMER: The information provided by Dell Children’s Medical Center of Texas (DCMCT), including but not limited to Clinical Pathways and Guidelines, protocols and outcome data, (collectively the "Information") is presented for the purpose of educating patients and providers on various medical treatment and management. The Information should not be relied upon as complete or accurate; nor should it be relied on to suggest a course of treatment for a particular patient. The Clinical Pathways and Guidelines are intended to assist physicians and other health care providers in clinical decision-making by describing a range of generally acceptable approaches for the diagnosis, management, or prevention of specific diseases or conditions. These guidelines should not be considered inclusive of all proper methods of care or exclusive of other methods of care reasonably directed at obtaining the same results. The ultimate judgment regarding care of a particular patient must be made by the physician in light of the individual circumstances presented by the patient. DCMCT shall not be liable for direct, indirect, special, incidental or consequential damages related to the user's decision to use this information contained herein. Definition: sexually active, including consensual and coerced sex7. An acute episode of heavy menstrual bleeding is one that, in Specific questions should be asked to determine possibility of the opinion of the clinician, is of sufficient quantity to require bleeding/coagulation disorder (see Table 2 in Addendum 1). immediate intervention to prevent future blood loss1.
    [Show full text]
  • Dysmenorrhea
    Pediatric & Adolescent Gynecology & Obstetrics Dysmenorrhea (Painful Periods) Defining Dysmenorrhea Painful menstruation — dysmenorrhea — is the most common menstrual disorder, with up to 90 percent of adolescent women experiencing pain with menses. Dysmenorrhea can be both primary and secondary in cause, and both forms are amenable to treatment. Primary dysmenorrhea is defined as painful menstruation in the absence of specific organic pathology, while secondary dysmenorrhea is related to conditions of the pelvic organs and may become worse over time. When a patient has painful periods, she and her family may be worried that it is a sign of a serious problem, such as cancer, or a threat to their reproductive potential. The vast majority of adolescents presenting with painful menses have primary dysmenorrhea and respond well to medical interventions. Conditions Associated With Secondary Dysmenorrhea Condition Description Endometriosis Tissue that normally lines the inside of the uterus grows outside the uterus, most commonly around the ovaries, intestines or other pelvic organs Müllerian duct anomalies Congenital (developmental) anomalies of the reproductive tract in which menstrual egress may be blocked Adenomyosis Tissue that normally lines the inside of the uterine cavity grows into the muscular wall of the uterus Fibroids Noncancerous growths of the uterus Salpingitis Inflammation of the fallopian tubes Pelvic adhesions Bands of scar tissue that can cause internal organs to be stuck together when they are not supposed to be Determining a Cause Referral Note: For any tests, procedures or imaging that are outside the scope of your regular pediatric or general practice, please refer the patient to Pediatric and Adolescent Gynecology at Nationwide Children’s Hospital.
    [Show full text]
  • Rare Thrombophilic Conditions
    342 Review Article Page 1 of 10 Rare thrombophilic conditions Gian Luca Salvagno1, Chiara Pavan2, Giuseppe Lippi1 1Section of Clinical Biochemistry, University of Verona, Verona, Italy; 2Division of Geriatric Medicine, Mater Salutis Hospital, Legnago, Verona, Italy Contributions: (I) Conception and design: GL Salvagno; (II) Administrative support: None; (III) Provision of study materials or patients: None; (IV) Collection and assembly of data: GL Salvagno, C Pavan; (V) Data analysis and interpretation: All authors; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Prof. Gian Luca Salvagno, MD, PhD. Sezione di Biochimica Clinica, Dipartimento di Neuroscienze, Biomedicina e Movimento, Università degli Studi di Verona, Ospedale Policlinico G.B. Rossi, Piazzale Scuro, 10, 37134 Verona, Italy. Email: [email protected]. Abstract: Thrombophilia, either acquired or inherited, can be defined as a predisposition to developing thromboembolic complications. Since the discovery of antithrombin deficiency in the 1965, many other conditions have been described so far, which have then allowed to currently detect an inherited or acquired predisposition in approximately 60–70% of patients with thromboembolic disorders. These prothrombotic risk factors mainly include qualitative or quantitative defects of endogenous coagulation factor inhibitors, increased concentration or function of clotting proteins, defects in the fibrinolytic system, impaired platelet function, and hyperhomocysteinemia. In this review article, we aim to provide an overview on epidemiologic, clinic and laboratory aspects of both acquired and inherited rare thrombophilic risk factors, especially including dysfibrinogenemia, heparin cofactor II, thrombomodulin, lipoprotein(a), sticky platelet syndrome, plasminogen activator inhibitor-1 apolipoprotein E, tissue factor pathway inhibitor, paroxysmal nocturnal haemoglobinuria and heparin-induced thrombocytopenia.
    [Show full text]